Leila Alland, Chief Medical Officer at PMV Pharmaceuticals, Inc. (PMVP), sold 6,633 shares at $33.39 ($222K) on 2021-06-07, disclosed to the SEC on 2021-06-08.
Open-market sale of $222k PMVP by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.39 | 2,633 | $88K | 39.5% |
| 2 | $33.39 | 2,633 | $88K | 39.5% |
| 3 | $34.00 | 1,367 | $46K | 20.9% |
| Total | $33.52 avg | 6,633 | $222K | 100% |
| Filing → |
| ABEO | BUY | 2024-05-20 | $52K | — | Filing → |
| ABEO | SELL | 2023-09-29 | $28K | — | Filing → |
| PMVP | SELL | 2023-09-18 | $42K | — | Filing → |